Global Medical REIT Inc.
| NYSE: GMRE | Real Estate / REITs / USA |
| 9.11 | +0.2000 | +2.24% | Vol 575.53K | 1Y Perf -45.40% |
| Mar 31st, 2023 16:00 DELAYED |
| BID | 8.80 | ASK | 9.11 | ||
| Open | 8.95 | Previous Close | 8.91 | ||
| Pre-Market | - | After-Market | 9.14 | ||
| - - | 0.03 0.33% |
| Target Price | 11.42 | Analyst Rating | Moderate Buy 2.14 | |
| Potential % | 25.36 | Finscreener Ranking | ★★+ 47.17 | |
| Insiders Trans % 3/6/12 mo. | -/100/100 | Value Ranking | ★+ 43.62 | |
| Insiders Value % 3/6/12 mo. | -/100/100 | Growth Ranking | ★★ 45.96 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/100/100 | Income Ranking | ★★ 38.58 | |
| Price Range Ratio 52W % | 22.23 | Earnings Rating | Sell | |
| Market Cap | 596.93M | Earnings Date | 3rd May 2023 | |
| Alpha | 0.01 | Standard Deviation | 0.08 | |
| Beta | 0.94 |
Today's Price Range 8.889.18 | 52W Range 7.0116.46 | 5 Year PE Ratio Range -74.90159.50 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 7.81% | ||
| 1 Month | -7.32% | ||
| 3 Months | -3.90% | ||
| 6 Months | 6.92% | ||
| 1 Year | -45.40% | ||
| 3 Years | -4.91% | ||
| 5 Years | 31.08% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | 0.52 | |||
ROE last 12 Months | 3.25 | |||
ROA (5Y Avg) | 0.12 | |||
ROA last 12 Months | 1.36 | |||
ROC (5Y Avg) | 2.27 | |||
ROC last 12 Months | 2.53 | |||
Return on invested Capital Q | 0.98 | |||
Return on invested Capital Y | 0.66 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 16.70 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 39.60 | ||||
| 1.13 | ||||
| 6.36 | ||||
| 8.50 | ||||
| -4.60 | ||||
| 1.16 | ||||
| 1.38 | ||||
| 8.76 | ||||
| 1.42B | ||||
| Forward PE | 9.17 | |||
| PEG | 4.95 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| 0.08 | ||||
| 1.21 | ||||
| 2.10 | ||||
| Leverage Ratio | 2.40 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 82.80 | ||||
| 34.70 | ||||
| 76.70 | ||||
| 11.20 | ||||
| 17.97 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 100.98M | ||||
| 1.54 | ||||
| 24.82 | ||||
| 48.21 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 8.57 | ||||
| 0.84 | ||||
| 8.18 | ||||
| 5.98 | ||||
| Payout ratio | 1.00K |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2022 | 0.24 | 0.24 | 0.00 |
| Q03 2022 | 0.24 | 0.25 | 4.17 |
| Q02 2022 | 0.24 | 0.25 | 4.17 |
| Q01 2022 | 0.23 | 0.24 | 4.35 |
| Q04 2021 | 0.23 | 0.24 | 4.35 |
| Q03 2021 | 0.23 | 0.24 | 4.35 |
| Q02 2021 | 0.22 | 0.23 | 4.55 |
| Q01 2021 | 0.22 | 0.24 | 9.09 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 12/2022 QR | 0.23 | -8.00 | Negative |
| 12/2022 FY | 0.92 | -3.16 | Negative |
| 3/2023 QR | 0.23 | -4.17 | Negative |
| 12/2023 FY | 0.94 | -6.93 | Negative |
| Next Report Date | 3rd May 2023 |
| Estimated EPS Next Report | 0.23 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | 8.00 |
| Volume Overview | |
|---|---|
| Volume | 575.53K |
| Shares Outstanding | 65.53K |
| Shares Float | 61.74M |
| Trades Count | 4.77K |
| Dollar Volume | 5.20M |
| Avg. Volume | 494.83K |
| Avg. Weekly Volume | 450.56K |
| Avg. Monthly Volume | 565.29K |
| Avg. Quarterly Volume | 468.64K |
Global Medical REIT Inc. (NYSE: GMRE) stock closed at 9.11 per share at the end of the most recent trading day (a 2.24% change compared to the prior day closing price) with a volume of 575.53K shares and market capitalization of 596.93M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the REITs industry, Real Estate sector and employs 4 people. Global Medical REIT Inc. CEO is Jeffrey Busch.
The one-year performance of Global Medical REIT Inc. stock is -45.4%, while year-to-date (YTD) performance is -3.9%. GMRE stock has a five-year performance of 31.08%. Its 52-week range is between 7.01 and 16.455, which gives GMRE stock a 52-week price range ratio of 22.23%
Global Medical REIT Inc. currently has a PE ratio of 39.60, a price-to-book (PB) ratio of 1.13, a price-to-sale (PS) ratio of 6.36, a price to cashflow ratio of 8.50, a PEG ratio of 2.32, a ROA of 1.36%, a ROC of 2.53% and a ROE of 3.25%. The company’s profit margin is 17.97%, its EBITDA margin is 76.70%, and its revenue ttm is $100.98 Million , which makes it $1.54 revenue per share.
Of the last four earnings reports from Global Medical REIT Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.23 for the next earnings report. Global Medical REIT Inc.’s next earnings report date is 03rd May 2023.
The consensus rating of Wall Street analysts for Global Medical REIT Inc. is Moderate Buy (2.14), with a target price of $11.42, which is +25.36% compared to the current price. The earnings rating for Global Medical REIT Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Global Medical REIT Inc. has a dividend yield of 8.57% with a dividend per share of $0.84 and a payout ratio of 1 000.00%.
Global Medical REIT Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.35, ATR14 : 0.29, CCI20 : -5.60, Chaikin Money Flow : -0.17, MACD : -0.36, Money Flow Index : 49.55, ROC : -3.50, RSI : 46.23, STOCH (14,3) : 68.37, STOCH RSI : 1.00, UO : 57.49, Williams %R : -31.63), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Global Medical REIT Inc. in the last 12-months were: Roscoe Moore (Option Excercise at a value of $0), Roscoe Moore (Sold 5 000 shares of value $48 957 )
Global Medical REIT Inc.
Global Medical REIT Inc is a United States-based company engaged primarily in the acquisition and leasing of licensed, purpose-built healthcare facilities in select markets with clinical operators with dominant market share. The company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals, and outpatient treatment centers. The company's healthcare facilities are typically leased, or under contract to be leased, under long-term triple-net leases on the date of purchase. The majority of the revenue is generated in the form of rental income.
CEO: Jeffrey Busch
Telephone: +1 202 524-6851
Address: 2 Bethesda Metro Center, Bethesda 20814, MD, US
Number of employees: 4
